Status:
COMPLETED
Comparative Microarray Analysis in Primary Cutaneous Malignant Melanoma
Lead Sponsor:
Ruhr University of Bochum
Conditions:
Cutaneous Malignant Melanoma
Eligibility:
All Genders
1+ years
Brief Summary
Perturbations in microRNA (miRNA) expression profiles has been reported for cutaneous malignant melanoma (CMM). This study will be an exploratory analysis by miRNA expression profiling using microarra...
Detailed Description
Perturbations in microRNA (miRNA) expression profiles has been reported for cutaneous malignant melanoma (CMM). With regards to a rapidly growing number of newly discovered miRNA sequences, the availa...
Eligibility Criteria
Inclusion
- Primary Cutaneous Malignant Melanoma
- Cutaneous Malignant Melanoma Metastases
- Benign Melanocytic Naevi
Exclusion
- \- Other Skin Cancer than Primary Cutaneous Malignant Melanoma
Key Trial Info
Start Date :
December 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
Estimated Enrollment :
21 Patients enrolled
Trial Details
Trial ID
NCT01482260
Start Date
December 1 2011
Last Update
November 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dermatology, Venereology and Allergology, Ruhr-University Bochum
Bochum, North Rhine-Westphalia, Germany, 44791